| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An account on the history of pharmacology in Spain
|
Aldea-Perona, Ana María
|
|
|
202 |
C |
p.
|
artikel
|
| 2 |
A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression
|
Hai, Yongrui
|
|
|
202 |
C |
p.
|
artikel
|
| 3 |
Beyond lectures and practical courses: Teaching pharmacology using imaginative pedagogical tools
|
Baños, J.E.
|
|
|
202 |
C |
p.
|
artikel
|
| 4 |
Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration
|
Song, Chao
|
|
|
202 |
C |
p.
|
artikel
|
| 5 |
Biological activities, Molecular mechanisms, and Clinical application of Naringin in Metabolic syndrome
|
Chen, Jie
|
|
|
202 |
C |
p.
|
artikel
|
| 6 |
CD39hi identifies an exhausted tumor-reactive CD8+ T cell population associated with tumor progression in human gastric cancer
|
Shen, Yang
|
|
|
202 |
C |
p.
|
artikel
|
| 7 |
CircBIRC6 facilitates the malignant progression via miR-488/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer
|
Tang, Zhiyuan
|
|
|
202 |
C |
p.
|
artikel
|
| 8 |
Comment on “Estrogen deficiency induces bone loss through the gut microbiota”
|
Detweiler, Priscilla
|
|
|
202 |
C |
p.
|
artikel
|
| 9 |
Contribution of Sub-Saharan African medicinal plants to cancer research: Scientific basis 2013–2023
|
Adico, Marc D.W.
|
|
|
202 |
C |
p.
|
artikel
|
| 10 |
Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis
|
Jiayi, Huang
|
|
|
202 |
C |
p.
|
artikel
|
| 11 |
Corrigendum to “A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation” [Pharmacol. Res. 194 (2023) 106851]
|
Gao, Feiqiong
|
|
|
202 |
C |
p.
|
artikel
|
| 12 |
Corrigendum to ‘Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease’ [Pharmacol Res. 174 (2021) 105973]
|
Kshirsagar, Sudhir
|
|
|
202 |
C |
p.
|
artikel
|
| 13 |
Corrigendum to “New therapies towards a better glycemic control in youths with type 1 diabetes” [Pharmacol. Res. 2023 Aug 3;195:106882]
|
Cardona-Hernandez, Roque
|
|
|
202 |
C |
p.
|
artikel
|
| 14 |
CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
|
Lv, Qi
|
|
|
202 |
C |
p.
|
artikel
|
| 15 |
D-arabinose acts as antidepressant by activating the ACSS2-PPARγ/TFEB axis and CRTC1 transcription
|
Guo, Yaxin
|
|
|
202 |
C |
p.
|
artikel
|
| 16 |
Editorial Board
|
|
|
|
202 |
C |
p.
|
artikel
|
| 17 |
FPR1: A critical gatekeeper of the heart and brain
|
Zhangsun, Ziyin
|
|
|
202 |
C |
p.
|
artikel
|
| 18 |
Functional significance of O-linked N-acetylglucosamine protein modification in regulating autophagy
|
Zhu, Zhuang
|
|
|
202 |
C |
p.
|
artikel
|
| 19 |
Gut Clostridium sporogenes-derived indole propionic acid suppresses osteoclast formation by activating pregnane X receptor
|
Peng, Renpeng
|
|
|
202 |
C |
p.
|
artikel
|
| 20 |
In vitro models for neuropathic pain phenotypic screening in brain therapeutics
|
Martínez, A.L.
|
|
|
202 |
C |
p.
|
artikel
|
| 21 |
IUPHAR-review: Targeting the cytoskeleton as a therapeutic approach to substance use disorders
|
Pandey, Surya
|
|
|
202 |
C |
p.
|
artikel
|
| 22 |
Kallistatin leads to cognition impairment via downregulating glutamine synthetase
|
Long, Yanlan
|
|
|
202 |
C |
p.
|
artikel
|
| 23 |
Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis
|
Sun, Yan
|
|
|
202 |
C |
p.
|
artikel
|
| 24 |
Natural products for combating multidrug resistance in cancer
|
Chen, Ting
|
|
|
202 |
C |
p.
|
artikel
|
| 25 |
peu-MIR2916-p3-enriched garlic exosomes ameliorate murine colitis by reshaping gut microbiota, especially by boosting the anti-colitic Bacteroides thetaiotaomicron – Correspondence
|
Huang, Xin-Zhi
|
|
|
202 |
C |
p.
|
artikel
|
| 26 |
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
|
Liu, Xiaohong
|
|
|
202 |
C |
p.
|
artikel
|
| 27 |
Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis
|
Zhang, Hu
|
|
|
202 |
C |
p.
|
artikel
|
| 28 |
Sirtuin 1 in osteoarthritis: Perspectives on regulating glucose metabolism
|
Liao, Zhihao
|
|
|
202 |
C |
p.
|
artikel
|
| 29 |
Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer’s disease
|
Wang, Yue
|
|
|
202 |
C |
p.
|
artikel
|
| 30 |
Targeting autophagy to counteract neuroinflammation: A novel antidepressant strategy
|
Gan, Hua
|
|
|
202 |
C |
p.
|
artikel
|
| 31 |
The role of epithelial cells in fibrosis: Mechanisms and treatment
|
Luo, Liuyi
|
|
|
202 |
C |
p.
|
artikel
|
| 32 |
Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies
|
Liu, Jiabin
|
|
|
202 |
C |
p.
|
artikel
|
| 33 |
Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9/STIM1-mediated ferroptosis
|
Ni, Jiahui
|
|
|
202 |
C |
p.
|
artikel
|
Tijdschrift beschrijving